Business Briefing: Senators Query Hepatitis C Drug’s High Costs
Friday, July 11, 2014 - 23:50
in Mathematics & Economics
Two members of the Senate Finance Committee asked Gilead Sciences to defend the more than $80,000 cost of Sovaldi, citing the expense to federal health care programs.